Start your Trading & Investing Journey with us

Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates

Anthem Biosciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Financial Information of Anthem Biosciences Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 19,302.85 Million, ₹ 14,830.69 Million and ₹ 11,339.92 Million. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 7,565.68 Million, ₹ 5,686.77 Million and ₹ 5,677.56 Million. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 4,512.59 Million, ₹ 
3,673.10 Million and ₹ 3,581.85 Million respectively. This indicates a steady growth in financial performance.

Anthem Biosciences Limited Financial Information (Restated Consolidated)

Amount in (₹ in Million)

Period Ended Mar 31, 2025 Mar 31, 2024 Mar 31, 2023
Reserve of Surplus 22,980.49 18,128.39 16,265.71
Total Assets 28,075.83 23,981.14 20,144.58
Total Borrowings 1,089.54 2,325.25 1,250.64
Fixed Assets 6,964.42 4,699.86 4,384.65
Cash 3,161.42 1,838.60 3,422.36
Cash flow from operating activities
Cash flows from investing activities
Cash flow from financing activities
Net Borrowing -2,071.88 486.65 -2,171.72
Revenue 19,302.85 14,830.69 11,339.92
EBITDA 7,565.68 5,686.77 5,677.56
PAT 4,512.59 3,673.10 3,851.85
PAT Margin
EPS 8.07 6.48 6.75

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Offer, given in 
FINANCIAL EXPRESS.

© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com